Savara to present at the barclays 26th annual global healthcare conference

Langhorne, pa.--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will participate in a fireside chat at the barclays 26th annual global healthcare conference on march 14, 2024 at 5:00am pt/8:00am et. a live webcast of the fireside chat will be available on savara's website at www.savarapharma.com/investors/events-presentations/ and will be archived for 90 days. about savara sava.
SVRA Ratings Summary
SVRA Quant Ranking